Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Jesse Lee Berry, MD

    TitleAssistant Professor of Clinical Ophthalmology
    SchoolKeck School of Medicine of USC
    AddressCHL 4650 Sunset Blvd
    Off Campus
    Los Angeles California 90027
    Phone+1 323 442 6578
    vCardDownload vCard

      Collapse Overview 
      Collapse Overview
      Dr. Jesse Berry is the Assistant Director of Ocular Oncology at the USC Eye Institute and Children’s Hospital Los Angeles. In addition, Dr. Berry is Associate Residency Program Director for the Los Angeles County + University of Southern California Ophthalmology residency program. She received her undergraduate and medical degree from Harvard University in Massachusetts. Following her ophthalmology residency at the University of Southern California, she was the assistant chief of service at the Los Angeles County Medical Center. She then completed a fellowship in ocular oncology at Children’s Hospital Los Angeles under the mentorship of Drs. Kim and Murphree. Dr. Berry is the founder of WOO, Women in Ocular Oncology. Her research endeavors focus on clinical outcomes of retinoblastoma and choroidal melanoma.

      Collapse Biography 
      Collapse Awards and Honors
      2000  - 2004Harvard College Scholarship: Elizabeth Cary Agassiz Scholar
      2000  - 2004Malcolm Kinsberg Scholarship
      2002Kappa Alpha Theta Foundation Scholarship
      2003David Rockefeller Center of Latin American Studies Grant
      2004  - 2008Nevil & Louise Ford Scholarship Fund
      2005Harvard Medical International Initiatives in Research Grant
      2007Center for Eye Research and Education McCleary Grant
      2011Doheny Eye Institute Medical Knowledge Award
      2012Starr Schulman Fellowship
      2012Department of Health Services Innovation Grant
      2013Society of Heed Fellows
      2013  - 2014University of Southern California Excellence in Resident Teaching Award

      Collapse ORNG Applications 
      Collapse Websites

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Berry J, Shah S, Bechtold M, Zolfaghari E, Jubran R, Kim JW. Long-term outcomes of Group D retinoblastoma eyes during the intravitreal melphalan era. Pediatr Blood Cancer. 2017 Jun 24. PMID: 28646513.
        View in: PubMed
      2. Berry J, Bechtold M, Shah S, Zolfaghari E, Reid M, Jubran R, Kim JW. Not All Seeds Are Created Equal: Seed Classification Is Predictive of Outcomes in Retinoblastoma. Ophthalmology. 2017 Jun 24. PMID: 28655537.
        View in: PubMed
      3. Wong BJ, Berry J. Acute Lymphoblastic Leukemia Relapse Presenting as Optic Nerve Infiltration. JAMA Ophthalmol. 2017 Jan 12; 135(1):e164656. PMID: 28030719.
        View in: PubMed
      4. Aziz HA, Kim JW, Munier FL, Berry J. Acute Hemorrhagic Retinopathy following Intravitreal Melphalan Injection for Retinoblastoma: A Report of Two Cases and Technical Modifications to Enhance the Prevention of Retinal Toxicity. Ocul Oncol Pathol. 2017 Jan; 3(1):34-40. PMID: 28275601.
        View in: PubMed
      5. Berry J, Cobrinik D, Kim JW. Detection and Intraretinal Localization of an 'Invisible' Retinoblastoma Using Optical Coherence Tomography. Ocul Oncol Pathol. 2016 Apr; 2(3):148-52. PMID: 27239455; PMCID: PMC4881267.
      6. Zhu D, Berry J, Ediriwickrema L, Wong K, Lee TC, Murphree AL, Kim JW, Jubran R. Long-Term Outcomes of Group B Eyes in Patients with Retinoblastoma Treated with Short-Course Chemoreduction: Experience from Children's Hospital Los Angeles/University of Southern California. Ocul Oncol Pathol. 2015 Dec; 2(2):105-11. PMID: 27172535; PMCID: PMC4847672.
      7. Browne AW, Dandapani SV, Jennelle R, Stevanovic M, Lee TC, Murphree AL, Kampp TD, Astrahan MA, Kim JW, Berry J. Outcomes of medium choroidal melanomas treated with ruthenium brachytherapy guided by three-dimensional pretreatment modeling. Brachytherapy. 2015 Sep-Oct; 14(5):718-25. PMID: 26073224.
        View in: PubMed
      8. Berry J, Jubran R, Lee TC, Murphree AL, Lee D, Kim JW. Low-Dose Chemoreduction for Infants Diagnosed with Retinoblastoma before 6 Months of Age. Ocul Oncol Pathol. 2015 Feb; 1(2):103-10. PMID: 27172253; PMCID: PMC4847682.
      9. Berry J, Dandapani SV, Stevanovic M, Lee TC, Astrahan M, Murphree AL, Kim JW. Outcomes of choroidal melanomas treated with eye physics: a 20-year review. JAMA Ophthalmol. 2013 Nov; 131(11):1435-42. PMID: 24008431.
        View in: PubMed
      10. Berry J, Cuzzo LM, Bababeygy SR, Quiros PA. Unmet need for corrective eyeglasses: results from a Los Angeles County Hospital survey. Int Ophthalmol. 2012 Jun; 32(3):245-50. PMID: 22487855.
        View in: PubMed
      11. Lee NG, Berry J, Lee TC, Wang AT, Honowitz S, Murphree AL, Varshney N, Hinton DR, Fawzi AA. Sonoporation enhances chemotherapeutic efficacy in retinoblastoma cells in vitro. Invest Ophthalmol Vis Sci. 2011 Jun 01; 52(6):3868-73. PMID: 21273549; PMCID: PMC3109062.
      12. Mavroeidi A, O'Neill F, Lee PA, Darling AL, Fraser WD, Berry J, Lee WT, Reid DM, Lanham-New SA, Macdonald HM. Seasonal 25-hydroxyvitamin D changes in British postmenopausal women at 57 degrees N and 51 degrees N: a longitudinal study. J Steroid Biochem Mol Biol. 2010 Jul; 121(1-2):459-61. PMID: 20302933.
        View in: PubMed
      13. Berry J, Small RC, Foster RW. Tracheal relaxation induced by potassium channel opening drugs: its antagonism by adrenergic neurone blocking agents. Br J Pharmacol. 1992 Aug; 106(4):813-8. PMID: 1393280; PMCID: PMC1907678.
      14. Small RC, Berry J, Boyle JP, Chapman ID, Elliott KR, Foster RW, Watt AJ. Biochemical and electrical aspects of the tracheal relaxant action of AH 21-132. Eur J Pharmacol. 1991 Jan 17; 192(3):417-26. PMID: 1647318.
        View in: PubMed